Geovax Labs Inc (GOVX) Company Profile & Statistics

Geovax Labs Inc
GOVX
(Nasdaq - US)
Closed
2.94
+0.24 (+8.89%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
After Market:2.91-0.03 (-1.02%)
Open
2.71
High
3.04
Low
2.70

About Geovax Labs Inc

CEO

David A. Dodd

Headquarters

1900 lake park drive, suite 380

smyrna, ga 30080, united states

Auditor

WIPFLI LLP

Employees

Share Holders

Website

www.geovax.com

Industry

biotechnology

Sector

health technology

Company Overview

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.

Geovax Labs Inc Statistics

Valuation Measures

Market Capitalization ²	27.75M
Enterprise Value	19.16M
Enterprise Value/EBITDA (ttm)	-0.79
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.66
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	50.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-473.17%
Return on Equity (ttm)	-809.87%
Return on Invested Capital (ttm)	-10759.52%
Return on Assets (ttm)	-349.34%

Income Statement

Revenue (ttm)	3.09M
Revenue Per Share (ttm)	0.33
Gross Profit (ttm)	3.09M
EBITDA (ttm)³	-24.40M
Net Income Avi to Common (ttm)	-24.32M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	3.10
52-Week Change	-63.23%
S&P500 52-Week Change	30.93%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	9.44M
Dividend Yield	0.00%
Float ⁴	8.90M
% Held by Insiders	5.70%
% Held by Institutions	6.09%

Balance Sheet

Total Cash (mrq)	8.59M
Total Cash Per Share (mrq)	0.91
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	4.17%
Quick Ratio (mrq)	4.17%
Book Value Per Share (mrq)	0.99

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.64
Free Cash Flow (ytd)	-16.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Geovax Labs Inc

Trade With A Regulated Broker